Advertisement Alphatec terminates license for Dynamo System - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Alphatec terminates license for Dynamo System

Alphatec and Scient'x have mutually terminated Alphatec's license from Scient'x of intellectual property related to the Dynamo Semi Rigid Rod System.

Terms of the termination include a repayment of the initial $2.6 million license fee originally paid to Scient’x and a full repayment of inventory that Alphatec will return to Scient’x.

Dirk Kuyper, president and CEO of Alphatec, said: “After a thorough portfolio review, Dynamo did not entirely fit within the new strategic direction of Alphatec and we plan on utilizing the $2.6 million repayment to support the commercialization of our innovative product development pipeline, such as OsseoScrew, V-Stent, GLIF, and other technologies targeted at the aging spine.”